BPC-157
Stable gastric pentadecapeptide discussed in soft-tissue and gut-adjacent preclinical work.
Overview
Often discussed in recovery and GI-adjacent research threads; not a treatment recommendation.
What it is
Pentadecapeptide derived from body protection compound (BPC) sequences.
Mechanism (high level)
Preclinical literature explores angiogenesis, tissue remodeling, and gut-barrier–adjacent models — human outcomes vary and require clinician context.
Quick facts
- Dosage
- ~250–500 mcg SubQ (education only)
- Route
- Subcutaneous (when discussed)
- Cycle
- 4–8+ weeks (literature-dependent)
- Storage
- Lyophilized: cool, dry; reconstituted: per pharmacy
Research indications
- Tendon / soft-tissue repair models (preclinical)
- GI-adjacent injury models (animal)
Research protocols (education)
Education-first logging template
Use PepTok to track adherence and notes; any protocol must be directed by a qualified clinician.
Interactions
Often avoided with
- Do not stack blindly with anticoagulants without medical oversight.
Often combined with
- Baseline recovery habits: sleep, protein, hydration.
Peptides discussed online are not substitutes for diagnosis or prescriptions.
Side effects & safety
- Injection-site irritation reported anecdotally.
- Stop and seek care for systemic allergic symptoms.
Regulatory notes
- Research-grade discussion only in many jurisdictions.
- Not FDA-approved for many uses discussed online.
FAQ
Is this a prescription?
PepTok does not provide prescriptions; it is for logging and education.
Related in catalog
Track in app
Save favorites, compare protocols, and track over time
PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.
Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.